Professor Bart De Strooper (UK Dementia Research Institute at UCL) has been awarded an honorary CBE for his services to ...

The 39-year-old from Hull lost his dad from Familial Alzheimer's disease (FAD) when he was a child and knew he had a 50:50 ...

Patients in Wales could be some of the first to benefit new research looking at how Artificial Intelligence combined with ...

MDRF, IISc`s CBR & UK DRI collaborate on groundbreaking research linking diabetes to brain health, cognitive decline, and ...

In the new study, the researchers demonstrated that the human brain falls asleep abruptly, rather than gradually, with a ‘tipping point’ marking the transition from wakefulness into sleep. They were ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and lecanemab, were rejected by the Scottish Medicines Consortium (SMC), ...

Alzheimer’s Research UK said the new study “adds to the growing evidence that repairing the blood-brain barrier (BBB) itself could offer a new way to treat Alzheimer’s,” but added that it is too early ...

A new drug could halt the progression of Alzheimer’s disease. Trials suggest the treatment, called trontinemab, could be the most powerful weapon yet against dementia. Research will now examine ...

A new MoU fosters collaboration between leading institutes to explore diabetes' impact on brain health and cognitive decline.

Regulatory authorities in the UK are being urged to speed their review of lecanemab (Leqembi, Eisai) after the US Food and Drug Administration (FDA) approved it for early-stage Alzheimer's disease.

Seven days of festive Black Friday offers gets underway at the Christmas Shopping Night event, from 5pm to 8pm.